SC
Silvia Crescioli
King's College London, The Antibody Society, University of Florence
Research areas: Immunology and Microbiology · Immunology · Cancer Immunotherapy and Biomarkers · Monoclonal and Polyclonal Antibodies Research · T-cell and B-cell Immunology
0000-0002-1909-5957
Employment
-
King's College London Visiting Research Fellow (Cancer Antibody Discovery and Immunotherapy Group)2023 - Present
-
The Antibody Society Business Intelligence Creator2023 - 2025
-
King's College London Postdoctoral Research Associate (Cancer Antibody Discovery and Immunotherapy Group)2014 - 2023
-
Università degli Studi di Firenze Research fellow2014 - 2014
-
Università degli Studi di Firenze PhD student, Research Fellow2011 - 2014
-
Università degli Studi di Firenze Research fellow2010 - 2011
Education
-
Università degli Studi di Firenze PhD in Biomedical Science (Experimental Pathology and Oncology)2011 - 2014
-
Università degli Studi di Firenze Master's Degree in Cellular and Molecular Biology2006 - 2009
-
Università degli Studi di Firenze Bachelor's Degree in Biological Sciences2003 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (62)
- Antibodies to watch in 2026 Save
- Antibodies to watch in 2025 Save
- YAbS: The Antibody Society’s antibody therapeutics database Save
- Non‐Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First‐In‐Class IgE Antibody Recognising Folate Receptor Alpha Save
- YAbS: The Antibody Society’s antibody therapeutics database Save
- With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process Save
- Antibodies to watch in 2024 Save
- IgE glycosylation and impact on structure and function: A systematic review Save
- AllergoOncology: Danger signals in allergology and oncology. A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper,AllergoOnkologie: Gefahrensignale in der Allergologie und Onkologie Ein Positionspapier der European Academy of Alle… Save
- Antibodies to watch in 2023 Save
- Data from Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer Save
- Data from Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer Save
- Supplementary materials and methods and Supplementary figure legends revised from Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer Save
- Supplementary materials and methods and Supplementary figure legends revised from Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer Save
- Supplementary tables and figures from Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer Save
- Supplementary tables and figures from Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer Save
- Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4 Save
- B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma Save
- Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes Save
- Antibodies to watch in 2022 Save